Oxazolopyridine and isoxazolopyridine derivatives for use in the treatment of HIF-mediated conditions
US8269008B2 · kind B2 · utility
28Cited by
6References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2008 |
| Grant date | Sep 18, 2012 |
| Priority date | — |
| Expiry date | Jul 5, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase enzyme.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.